Evidence map›Paper›PMID 23468959›Full record

ArticlePloS one2013

Tristetraprolin mediates radiation-induced TNF-α production in lung macrophages.

Dipankar Ray, Shirish Shukla, Uday Sankar Allam, Abigail Helman, Susmita Gurjar Ramanand, Linda Tran, Michael Bassetti, Pranathi Meda Krishnamurthy, Matthew Rumschlag, Michelle Paulsen and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Immunocompetent mouse models revealed that S100A4Emerging microbes & infections · 2024
    Article
  4. Article
  5. Article
  6. Biology of Radiation-Induced Lung Injury.Seminars in radiation oncology · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Dipankar RayDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States of America. dipray@umich.edu
Shirish Shukla
Uday Sankar Allam
Abigail Helman
Susmita Gurjar Ramanand
Linda Tran
Michael Bassetti
Pranathi Meda Krishnamurthy
Matthew Rumschlag
Michelle Paulsen
Lei Sun
Thomas P Shanley
Mats Ljungman
Mukesh K Nyati
Ming Zhang
Theodore S Lawrence
Michigan United · USUniversity of Michigan–Ann Arbor · USMichigan Medicine · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Scott Michael Schuetze · 1988 to 2026
$178.2M
Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI John D. Meeker · 2011 to 2026
$21.5M
ENVIRONMENTAL TOXICOLOGY PRE/POST DOCTORAL RES.TRAININGT32ES007062 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Justin Adam Colacino · 1985 to 2026
$10.5M
SHORT-TERM TRAINING IN HEALTH PROF SCHOOLST35HL007690 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FLAHERTY, KEVIN R · 1990 to 2024
$3.3M
Targeting SMURF2 as a novel therapy for EGFR driven tumorsR01CA160981 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAY, DIPANKAR · 2011 to 2015
$1.4M
Lung radioprotection by inhibition of TNF-alpha and TGF-beta1R01CA127477 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZHANG, MING · 2009 to 2012
$1.3M
NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA127477NCI NIH HHS R01CA127477NCI NIH HHS R01 CA160981NHLBI NIH HHS T35 HL007690NIEHS NIH HHS P30 ES017885NIEHS NIH HHS T32 ES007062
6 · The paper itself

Abstract

The efficacy of radiation therapy for lung cancer is limited by radiation-induced lung toxicity (RILT). Although tumor necrosis factor-alpha (TNF-α) signaling plays a critical role in RILT, the molecular regulators of radiation-induced TNF-α production remain unknown. We investigated the role of a major TNF-α regulator, Tristetraprolin (TTP), in radiation-induced TNF-α production by macrophages. For in vitro studies we irradiated (4 Gy) either a mouse lung macrophage cell line, MH-S or macrophages isolated from TTP knockout mice, and studied the effects of radiation on TTP and TNF-α levels. To study the in vivo relevance, mouse lungs were irradiated with a single dose (15 Gy) and assessed at varying times for TTP alterations. Irradiation of MH-S cells caused TTP to undergo an inhibitory phosphorylation at Ser-178 and proteasome-mediated degradation, which resulted in increased TNF-α mRNA stabilization and secretion. Similarly, MH-S cells treated with TTP siRNA or macrophages isolated from ttp (-/-) mice had higher basal levels of TNF-α, which was increased minimally after irradiation. Conversely, cells overexpressing TTP mutants defective in undergoing phosphorylation released significantly lower levels of TNF-α. Inhibition of p38, a known kinase for TTP, by either siRNA or a small molecule inhibitor abrogated radiation-induced TNF-α release by MH-S cells. Lung irradiation induced TTP(Ser178) phosphorylation and protein degradation and a simultaneous increase in TNF-α production in C57BL/6 mice starting 24 h post-radiation. In conclusion, irradiation of lung macrophages causes TTP inactivation via p38-mediated phosphorylation and proteasome-mediated degradation, leading to TNF-α production. These findings suggest that agents capable of blocking TTP phosphorylation or stabilizing TTP after irradiation could decrease RILT.

Indexed as

AnimalsBase SequenceCell LineDNA PrimersLungMacrophages, AlveolarMicep38 Mitogen-Activated Protein KinasesPhosphorylationRNA, MessengerTristetraprolinTumor Necrosis Factor-alphaDNA Primersp38 Mitogen-Activated Protein KinasesRNA, MessengerTristetraprolinTumor Necrosis Factor-alpha

Identifiers

PMID23468959
PMCPMC3585360
OpenAlexW2041609569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.